BCR/ABL, mRNA translation and apoptosis

被引：16
|
作者：
Perrotti, D
Turturro, F
Neviani, P
机构：
[1] Ohio State Univ, Div Human Canc Genet, Dept Mol Virol Immunol & Med Genet, Human Canc Genet Program, Columbus, OH 43240 USA
[2] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA
[3] Louisiana State Univ, Hlth Sci Ctr, Gene Therapy Program, Feist Weiller Canc Ctr, Shreveport, LA 71105 USA
来源：
CELL DEATH AND DIFFERENTIATION | 2005年 / 12卷 / 06期
关键词：
D O I：
10.1038/sj.cdd.4401606
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页码：534 / 540
页数：7
相关论文
共 50 条
  • [1] BCR/ABL, mRNA translation and apoptosis
    D Perrotti
    F Turturro
    P Neviani
    Cell Death & Differentiation, 2005, 12 : 534 - 540
  • [2] Arsenic trioxide inhibits translation of mRNA of bcr-abl, resulting in attenuation of Bcr-Abl levels and apoptosis of human leukemia cells
    Nimmanapalli, R
    Bali, P
    O'Bryan, E
    Fuino, L
    Guo, F
    Wu, J
    Houghton, P
    Bhalla, K
    CANCER RESEARCH, 2003, 63 (22) : 7950 - 7958
  • [3] A novel mechanism for Bcr-Abl action: Bcr-Abl-mediated induction of the eIF4F translation initiation complex and mRNA translation
    Prabhu, S.
    Saadat, D.
    Zhang, M.
    Halbur, L.
    Fruehauf, J. P.
    Ong, S. T.
    ONCOGENE, 2007, 26 (08) : 1188 - 1200
  • [4] A novel mechanism for Bcr-Abl action: Bcr-Abl-mediated induction of the eIF4F translation initiation complex and mRNA translation
    S Prabhu
    D Saadat
    M Zhang
    L Halbur
    J P Fruehauf
    S T Ong
    Oncogene, 2007, 26 : 1188 - 1200
  • [5] BCR/ABL activates mdm2 mRNA translation via the La antigen.
    Trotta, R
    Vignudelli, T
    Pecorari, L
    Candini, O
    Guerzoni, C
    Santilli, G
    Byrom, M
    Goldoni, S
    Ford, L
    Caligiuri, MA
    Perrotti, D
    Calabretta, B
    BLOOD, 2002, 100 (11) : 582A - 582A
  • [6] A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation
    Notari, M
    Neviani, P
    Santhanam, R
    Blaser, BW
    Chang, JS
    Galietta, A
    Willis, AE
    Roy, DC
    Caligiuri, MA
    Marcucci, G
    Perrotti, D
    BLOOD, 2006, 107 (06) : 2507 - 2516
  • [7] A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation
    Notari, Mario
    CANCER RESEARCH, 2006, 66 (08)
  • [8] BCR/ABL oncogene controls MICA translation.
    Boissel, N
    Rea, D
    Tieng, V
    Dulphy, N
    Brun, M
    Cayuela, JM
    Rousselot, P
    Tamouza, R
    Le Bouteiller, P
    Mahon, FX
    Steinle, A
    Charron, D
    Dombret, H
    Toubert, A
    BLOOD, 2005, 106 (11) : 176B - 176B
  • [9] EUROPEAN STANDARDIZATION OF BCR-ABL MRNA QUANTIFICATION
    Mueller, M. C.
    Erben, P.
    Saglio, G.
    Branford, S.
    Hanfstein, B.
    Gosenca, D.
    Ernst, T.
    Hehlmann, R.
    Cross, N. C. P.
    Hochhaus, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 61 - 61
  • [10] BCR/ABL mRNA Targeting Small Interfering RNA Effects on Proliferation and Apoptosis in Chronic Myeloid Leukemia
    Zhu, Xi-Shan
    Lin, Zi-Ying
    Du, Jing
    Cao, Guang-Xin
    Liu, Gang
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (12) : 4773 - 4780
12345